BJU International (ISSN 1464-4096) is a prestigious monthly peer-reviewed journal published by Wiley-Blackwell in the United Kingdom, widely recognized as a leading venue for high-impact research in urology. As an SCI-indexed publication, it consistently maintains a strong standing in academic rankings, typically situated in the second or third quartile of the medical sciences category according to the Chinese Academy of Sciences journal ranking system. The journal encompasses a broad spectrum of urological topics, including urological oncology, stone disease, male reproductive health, surgical innovations, and fundamental research, with a particular emphasis on bridging the gap between clinical practice and translational medicine. While BJU International operates under a hybrid access model rather than being fully open access, it offers selective open access options to enhance the dissemination of its findings. Known for its rigorous peer-review process and high acceptance standards, the journal attracts intense competition from the global research community, resulting in a high rejection rate and potentially extended publication timelines. Nevertheless, the high academic value and significant influence of the articles it publishes solidify its reputation as an essential resource for scholars, clinicians, and researchers dedicated to advancing the field of urology.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com